Immediate Impact
43 standout
Citing Papers
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
2024 Standout
Targeting TIGIT for cancer immunotherapy: recent advances and future directions
2024 Standout
Works of Han Yan being referenced
768 Peripheral pharmacodynamic (PD) effects of ociperlimab (OCI) in combination with tislelizumab (TIS) in patients with advanced solid tumors: AdvanTIG-105 Phase 1 dose-escalation study
2022
Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
2022
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Han Yan | 161 | 117 | 75 | 96 | 111 | 937 | |
| Yuxin Huang | 194 | 84 | 50 | 19 | 95 | 996 | |
| Fengwei Zhang | 262 | 228 | 40 | 83 | 96 | 1.0k | |
| Chun Fu | 197 | 51 | 35 | 42 | 89 | 760 | |
| Xia Zhao | 304 | 65 | 63 | 141 | 46 | 1.1k | |
| Hao Bai | 320 | 127 | 39 | 15 | 86 | 1.1k | |
| Ying Zhang | 236 | 48 | 40 | 42 | 90 | 871 | |
| Yu Liu | 164 | 27 | 262 | 127 | 52 | 805 | |
| Min Liu | 219 | 95 | 17 | 39 | 120 | 958 | |
| Jingyi Li | 247 | 71 | 31 | 29 | 85 | 868 | |
| Vivian Wang | 237 | 119 | 84 | 9 | 34 | 990 |
All Works
Login with ORCID to disown or claim papers
Loading papers...